Skip to main content
. 2018 Nov 26;144(3):489–502. doi: 10.1002/ijc.31858

Table 2.

SNPs significantly associated with risk of colorectal adenomas in the study population

SNP Normal Adenoma
(Gene) Genetic model Genotype n n OR 95% CI p‐value1 FDR2
rs10505477 Recessive A/A‐A/G 653 436 1.00 Reference 0.014 0.033
CASC8 G/G 184 85 0.69 0.52 0.93
rs6983267 Recessive G/G‐G/T 647 427 1.00 Reference 0.010 0.033
CASC8 T/T 175 77 0.67 0.50 0.91
rs13181 Recessive T/T‐G/T 727 470 1.00 Reference 0.015 0.033
ERCC2 G/G 110 50 0.64 0.44 0.92
rs1728785 Recessive C/C‐A/C 773 503 1.00 Reference <0.001 0.015
ZFP90 A/A 62 18 0.41 0.24 0.72
rs8180040 Recessive T/T‐A/T 686 456 1.00 Reference 0.003 0.026
PTPN23 A/A 150 66 0.62 0.45 0.86
rs16260 Recessive C/C‐A/C 758 489 1.00 Reference 0.013 0.033
CDH1 A/A 79 34 0.59 0.38 0.91
rs9929218 Recessive G/G‐A/G 756 489 1.00 Reference 0.005 0.029
CDH1 A/A 83 34 0.55 0.36 0.84

OR: Odds ratio. CI: confidence interval. FDR: False Discovery Rate. n: number of individuals.

1

ORs and p‐values adjusted by age, gender, tobacco, alcohol, drugs use (NSAIDs and low‐dose ASA), and family history of CRC.

2

p‐values obtained after applying the False Discovery Rate (FDR) test for multiple corrections. FDR values <0.05 are highlighted in bold. Only those models with significant FDR p‐values are shown in the table.